Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Compound 4 is a promising treatment for hair loss with low toxicity.

Lamivudine might reverse hair graying and needs more research for potential treatments.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

The combination treatment showed a higher response rate but no significant survival benefits.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Decomposed tritiated thymidine is less accurate for DNA tracing, and hair changes can indicate malnutrition.

Axitinib treatment turned a man's grey hair back to black.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Tofacitinib might be used to treat hair loss.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.